Literature DB >> 10559837

Targeting and translocation of endothelial nitric oxide synthase.

T Michel1.   

Abstract

This review explores advances in our understanding of the intracellular regulation of the endothelial isoform of nitric oxide synthase (eNOS) in the context of its dynamically regulated subcellular targeting. Nitric oxide (NO) is a labile molecule, and may play important biological roles both within the cell in which it is synthesized and in its interactions with nearby cells and molecules. The localization of eNOS within the cell importantly influences the biological role and chemical fate of the NO produced by the enzyme. eNOS, a Ca2+/calmodulin-dependent enzyme, is subject to a complex pattern of intracellular regulation, including co- and post-translational modifications and interactions with other proteins and ligands. In endothelial cells and cardiac myocytes eNOS is localized in specialized plasmalemmal signal-transducing domains termed caveolae; acylation of the enzyme by the fatty acids myristate and palmitate is required for targeting of the protein to caveolae. Targeting to caveolae facilitates eNOS activation following receptor stimulation. In resting cells, eNOS is tonically inhibited by its interactions with caveolin, the scaffolding protein in caveolae. However, following agonist activation, eNOS dissociates from caveolin, and nearly all the eNOS translocates to structures within the cell cytosol; following more protracted incubations with agonists, most of the cytosolic enzyme subsequently translocates back to the cell membrane. The agonist-induced internalization of eNOS is completely abrogated by chelation of intracellular Ca2+. These rapid receptor-mediated effects are seen not only for "classic" eNOS agonists such as bradykinin, but also for estradiol, indicating a novel non-genomic role for estrogen in eNOS activation. eNOS targeting to the membrane is labile, and is subject to receptor-regulated Ca2+-dependent reversible translocation, providing another point for regulation of NO-dependent signaling in the vascular endothelium.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559837     DOI: 10.1590/s0100-879x1999001100006

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  14 in total

1.  De novo lipogenesis maintains vascular homeostasis through endothelial nitric-oxide synthase (eNOS) palmitoylation.

Authors:  Xiaochao Wei; Jochen G Schneider; Sherene M Shenouda; Ada Lee; Dwight A Towler; Manu V Chakravarthy; Joseph A Vita; Clay F Semenkovich
Journal:  J Biol Chem       Date:  2010-11-23       Impact factor: 5.157

2.  Where is endothelial nitric oxide synthase more critical: plasma membrane or Golgi?

Authors:  Zheng-Gen Jin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-05       Impact factor: 8.311

Review 3.  Regulation of cellular communication by signaling microdomains in the blood vessel wall.

Authors:  Marie Billaud; Alexander W Lohman; Scott R Johnstone; Lauren A Biwer; Stephanie Mutchler; Brant E Isakson
Journal:  Pharmacol Rev       Date:  2014-03-26       Impact factor: 25.468

Review 4.  Nitric oxide synthases: structure, function and inhibition.

Authors:  W K Alderton; C E Cooper; R G Knowles
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

5.  A fluorescence-activated cell sorter analysis of the relationship between protein kinase G and endothelial nitric oxide synthase.

Authors:  Theresa A John; J Usha Raj
Journal:  Anat Rec (Hoboken)       Date:  2010-07-22       Impact factor: 2.064

6.  Functional role of HSP90 complexes with endothelial nitric-oxide synthase (eNOS) and calpain on nitric oxide generation in endothelial cells.

Authors:  Monica Averna; Roberto Stifanese; Roberta De Tullio; Mario Passalacqua; Franca Salamino; Sandro Pontremoli; Edon Melloni
Journal:  J Biol Chem       Date:  2008-08-05       Impact factor: 5.157

7.  Activation of vascular endothelial nitric oxide synthase and heme oxygenase-1 expression by electrophilic nitro-fatty acids.

Authors:  Nicholas K H Khoo; Volker Rudolph; Marsha P Cole; Franca Golin-Bisello; Francisco J Schopfer; Steven R Woodcock; Carlos Batthyany; Bruce A Freeman
Journal:  Free Radic Biol Med       Date:  2009-10-24       Impact factor: 7.376

8.  The Contrary Impact Of Diabetes And Exercise On Endothelial Nitric Oxide Synthase Function.

Authors:  Nazar Labinskyy; Steven Hicks; James Grijalva; John Edwards
Journal:  Webmedcentral       Date:  2010-12-28

9.  Platelet activating factor-induced ceramide micro-domains drive endothelial NOS activation and contribute to barrier dysfunction.

Authors:  Sanda Predescu; Ivana Knezevic; Cristina Bardita; Radu Florin Neamu; Viktor Brovcovych; Dan Predescu
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

10.  KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation.

Authors:  Sucharita SenBanerjee; Zhiyong Lin; G Brandon Atkins; Daniel M Greif; Ravi M Rao; Ajay Kumar; Mark W Feinberg; Zhiping Chen; Daniel I Simon; F William Luscinskas; Thomas M Michel; Michael A Gimbrone; Guillermo García-Cardeña; Mukesh K Jain
Journal:  J Exp Med       Date:  2004-05-10       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.